All Stories

  1. Emerging Pathogens Causing Acute Hepatitis
  2. Risks and Preventions for Pregnant Women and Their Preterm Infants in a World with COVID-19: A Narrative Review
  3. Is Hepatitis E Virus a Neglected or Emerging Pathogen in Egypt?
  4. Assessment of Knowledge, Attitude, and Practice among Saudi Residents Regarding Hepatitis E Virus
  5. Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway
  6. Health Hazards Assessment and Geochemistry of ElSibai-Abu ElTiyur Granites, Central Eastern Desert, Egypt
  7. Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 Mpro Inhibitors from Penicillium citrinum TDPEF34
  8. Role of polymeric materials in preventing COVID-19 infection
  9. Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling
  10. A Novel Vaccine Selection Decision-Making Model (VSDMM) for COVID-19
  11. Interleukin-18 and interferon-γ single nucleotide polymorphisms in Egyptian patients with tuberculosis
  12. Exploration of Knowledge, Attitude, and Practice Among Residents of Saudi Arabia Toward Hepatitis Viruses
  13. Synergistic antifungal activity of mixtures of clove, cumin and caraway essential oils and their major active components
  14. Prevalence of methicillin-resistant coagulase-negative staphylococci among Egyptian patients after surgical interventions
  15. Association of the polymorphism of the Toll‐like receptor (TLR)‐3 and TLR‐9 genes with hepatitis C virus‐specific cell‐mediated immunity outcomes among Egyptian health‐care workers
  16. Alternatively activated macrophages; a double-edged sword in allergic asthma
  17. Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia
  18. Investigation of plasmid-mediated quinolone resistance in pseudomonas in Saudi Arabia
  19. Design and total synthesis of (-)-codonopsinine, (-)-codonopsine and codonopsinine analogues by O-(2-oxopyrrolidin-5-yl)trichloroacetimidate as amidoalkylating agent with improved antimicrobial activity via solid lipid nanoparticle formulations
  20. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians
  21. High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection
  22. RNA protein kinase SNP at -226 C
  23. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians
  24. Topical Eugenol Successfully Treats Experimental <b><i>Candida albicans</i></b>-Induced Keratitis
  25. Incidence and characteristics of hepatitis E virus infection in children in Assiut, Upper Egypt
  26. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients
  27. Multi-drug-resistant Enterococcus faecalis among Egyptian patients with urinary tract infection
  28. Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin
  29. Molecular Typing of Methicillin Resistant Staphylococcus aureus Colonizing Egyptian Healthcare Workers and Patients
  30. Association of Interleukin-27 rs 153109 Single Nucleotide Polymorphism with Spontaneous Resolution of Hepatitis C Virus - Genotype 4a Infection in Egyptian Patients
  31. Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?
  32. Occult hepatitis C virus infection among Egyptian hemodialysis patients
  33. P-B10 Egyptian healthcare workers and Hepatitis C virus vaccines
  34. Design, Synthesis, and Molecular Docking of Novel Pyrrolooxazepinediol Derivatives with Anti-Influenza Neuraminidase Activity
  35. Is hepatitis E virus an emerging problem in industrialized countries?
  36. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection
  37. Changing Patterns of Drug-ResistantShigellaIsolates in Egypt
  38. The emergence of hepatitis E virus in Europe
  39. Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response
  40. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians
  41. Prevalence of Methicillin Resistant Staphylococcus aureus among Egyptian Patients after Surgical Interventions
  42. Cross Reactive Cellular Immune Response to HCV Genotype 1 and 4 Antigens among Genotype 4 Exposed Subjects
  43. Increased quinolone resistance among typhoid Salmonella isolated from Egyptian patients
  44. Schistosomiasis Does Not Affect the Outcome of HCV Infection in Genotype 4-Infected Patients
  45. Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection
  46. Hepatitis C Virus-Specific Cell-Mediated Immune Responses in Children Born to Mothers Infected with Hepatitis C Virus
  47. Hepatitis B Virus Genotype D Predominates HBsAg-Positive Egyptian Blood Donors
  48. Predominant Th1 cytokines in seronegative, aviremic children who exhibit HCV-specific cell-mediated immune response
  49. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt
  50. Hepatitis C Virus-Multispecific T-Cell Responses without Viremia or Seroconversion among Egyptian Health Care Workers at High Risk of Infection
  51. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre
  52. Strong Hepatitis C Virus (HCV)–specific Cell-mediated Immune Responses in the Absence of Viremia or Antibodies Among Uninfected Siblings of HCV Chronically Infected Children
  53. Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach
  54. ‘Self-Protection’ of Individual CD4+ T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands
  55. Antigen stimulation induces HIV envelope gp120-specific CD4+ T cells to secrete CCR5 ligands and suppress HIV infection
  56. Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay
  57. Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses
  58. Cholera Toxin Indirectly Activates Human Monocyte-Derived Dendritic Cells In Vitro through the Production of Soluble Factors, Including Prostaglandin E2 and Nitric Oxide
  59. Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection
  60. EXPOSURE TO HEPATITIS C VIRUS INDUCES CELLULAR IMMUNE RESPONSES WITHOUT DETECTABLE VIREMIA OR SEROCONVERSION
  61. Pasteurella multocida Toxin Activates Human Monocyte-Derived and Murine Bone Marrow-Derived Dendritic Cells In Vitro but Suppresses Antibody Production In Vivo
  62. Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization
  63. HIV-1 transgenic rats develop T cell abnormalities
  64. Calcium Signaling through Phospholipase C Activates Dendritic Cells To Mature and Is Necessary for the Activation and Maturation of Dendritic Cells Induced by Diverse Agonists
  65. An Enzymatically Active A Domain Is Required for Cholera-Like Enterotoxins To Induce a Long-Lived Blockade on the Induction of Oral Tolerance: New Method for Screening Mucosal Adjuvants
  66. HIV-1-suppressive factors are secreted by CD4+T cells during primary immune responses
  67. Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway
  68. Perforin-low memory CD8+cells are the predominant T cells in normal humans that synthesize the β-chemokine macrophage inflammatory protein-1β